Amgen
The Senior Manager, Strategic Planning & Operations, Inflammation Research at Amgen serves as a strategic partner to the VP Research and the Inflammation Leadership Team, translating therapeutic area strategy into measurable priorities, operating plans, and outcomes. The role oversees strategic planning, portfolio governance, technology and AI initiatives, organizational effectiveness, and executive communications to accelerate the delivery of transformative medicines.
Headquarters
Thousand Oaks, California, United States
Company Size
10001+ employees
Founded
1980
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Amgen.
27% above the average for this role
Gilead Gets a Buy, Amgen a Hold and ORIC a Vote of Confidence: Wall Street's Latest Biopharma Calls Explained
1 day ago
Director, Analysis Oversight Lead RWE: Inflammation
Gilead Sciences
Manager, gRED Portfolio Strategy and Planning
1000 Genentech, Inc.
Director, Strategic Planning
GISP
Director, Strategic Planning & Operations for BAI (Business Analytics and
lifelancer
Strategic Planning & Operations Sr Mgr
lifelancer
Scientist, In Vivo Pharmacology, Inflammation Research
lifelancer